NCT00751387已完成不适用
Australian Descriptive Epidemiology Study of Severity of Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) and Ankylosing Spondylitis (AS) and Exposure to Biological Disease Modifying Anti-rheumatic Drugs (bDMARDs)
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 559 人开始时间: 2008年11月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 559
- 主要终点
- Proportion of rheumatoid arthritis/psoriatic arthritis/ankylosing spondylitis patients in defined disease severity categories
研究概览
简要总结
The study is a cross sectional, epidemiology study of disease severity for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis in four geographic regions in Australia (Illawarra, Sutherland, Hunter Urban and Hunter Rural).
研究设计
- 研究类型
- Observational
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Proportion of rheumatoid arthritis/psoriatic arthritis/ankylosing spondylitis patients in defined disease severity categories
时间窗: Single visit
次要结局
- Proportion of patients exposed to biological disease modifying antirheumatic drugs(Single visit)
研究者
相似试验
撤回
不适用
Assessment of the Disease Severity and Treatment Patterns of Rheumatoid Arthritis in Eastern Europe, Middle East and North African Countries (P08167)Arthritis, RheumatoidNCT01313871Merck Sharp & Dohme LLC
已完成
不适用
Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque PsoriasisArthritis, PsoriaticPsoriasisNCT00998829Pfizer458
已完成
不适用
Study Evaluating Health Related Utility in Rheumatoid ArthritisRheumatoid ArthritisNCT00471874Wyeth is now a wholly owned subsidiary of Pfizer250
Unknown
2 期
Efficacy and Safety of TwHF and MTX in Patients With Rheumatoid ArthritisRheumatoid ArthritisNCT03324412Guang'anmen Hospital of China Academy of Chinese Medical Sciences216
Unknown
2 期
A Specification Clinical Application Research of Tripterygium Wilfordii Treating Rheumatoid ArthritisRheumatoid ArthritisNCT03337815Guang'anmen Hospital of China Academy of Chinese Medical Sciences264
